Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer/Wyeth Will Produce (Incremental) Growth, Pfizer Assures Investors

This article was originally published in PharmAsia News

Executive Summary

Pfizer management, more bullish than the Street on long-term revenue forecasts for the combination of Pfizer and Wyeth, assured investors that incremental growth opportunities will emerge from the mega merger during a follow-up meeting with investors Jan. 27
Advertisement

Related Content

Japanese Pharmas Investing Heavily in Emerging Markets - BioJapan Conference
Japanese Pharmas Investing Heavily in Emerging Markets - BioJapan Conference
Pfizer To Become Largest Pharma In Japan After Wyeth Merger
Pfizer To Become Largest Pharma In Japan After Wyeth Merger
Pfizer To Become Largest Pharma In Japan After Wyeth Merger
Pfizer Signs Big Bang Deal With Aurobindo For Larger Presence in Generics; Biosimilars Next ?
Pfizer Looks At India For New Growth Avenues To Accelerate Innovation
Eisai Sees Generics Opportunity In Japan For Innovator Companies
With Wyeth, Pfizer To Become Second-largest Multinational Pharma In India
With Wyeth, Pfizer To Become Second-largest Multinational Pharma In India
Advertisement
UsernamePublicRestriction

Register

SC070865

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel